N-of-1 trial: most statin side effects arose with placebo too, pointing to nocebo
Louis highlights a NEJM N-of-1 trial where people who had stopped statins for side effects received four months of statin, four of placebo and four of nothing, randomly ordered. Symptoms with placebo were about the same as with statin, and half could restart statins; Louis infers about 90% of side effects were nocebo.








